Liu, Y.-Y.; Lin, C.-L.; Weng, C.-H.; Chang, P.-H.; Chien, C.-H.; Huang, K.-C.; Hua, M.-C.; Hu, C.-C.
Older Age and High α-Fetoprotein Predict Higher Risk of Hepatocellular Carcinoma in Chronic Hepatitis-B-Related Cirrhotic Patients Receiving Long-Term Nucleos(t)ide Analogue Therapy. Diagnostics 2022, 12, 2085.
https://doi.org/10.3390/diagnostics12092085
AMA Style
Liu Y-Y, Lin C-L, Weng C-H, Chang P-H, Chien C-H, Huang K-C, Hua M-C, Hu C-C.
Older Age and High α-Fetoprotein Predict Higher Risk of Hepatocellular Carcinoma in Chronic Hepatitis-B-Related Cirrhotic Patients Receiving Long-Term Nucleos(t)ide Analogue Therapy. Diagnostics. 2022; 12(9):2085.
https://doi.org/10.3390/diagnostics12092085
Chicago/Turabian Style
Liu, Yuh-Ying, Chih-Lang Lin, Cheng-Hao Weng, Pei-Hung Chang, Cheng-Hung Chien, Kuang-Chen Huang, Man-Chin Hua, and Ching-Chih Hu.
2022. "Older Age and High α-Fetoprotein Predict Higher Risk of Hepatocellular Carcinoma in Chronic Hepatitis-B-Related Cirrhotic Patients Receiving Long-Term Nucleos(t)ide Analogue Therapy" Diagnostics 12, no. 9: 2085.
https://doi.org/10.3390/diagnostics12092085
APA Style
Liu, Y.-Y., Lin, C.-L., Weng, C.-H., Chang, P.-H., Chien, C.-H., Huang, K.-C., Hua, M.-C., & Hu, C.-C.
(2022). Older Age and High α-Fetoprotein Predict Higher Risk of Hepatocellular Carcinoma in Chronic Hepatitis-B-Related Cirrhotic Patients Receiving Long-Term Nucleos(t)ide Analogue Therapy. Diagnostics, 12(9), 2085.
https://doi.org/10.3390/diagnostics12092085
